... Joint Bone Spine 2003, 70:458-464 Barry HC: Paget'sDiseaseofBone London: E & S Livingstone; 1969 Huvos AG, Butler A, Bretsky SS: Osteogenic sarcoma associated with Paget'sdiseaseof bone: ... Biosystems, Foster City, CA, USA) Results Clinical data Suspicion or diagnosis of PDB was based on description by relatives, evidence ofbone deformities and pain strongly suggestive of PDB (II-3 ... application of genetic analyses in families is the precocious identification of asymptomatic gene carriers In this relative the p62/SQSTM1 disease- associated mutation was also present in individuals younger...
... Epidemiology ofPaget'sdiseaseofboneBone 1999, 24: 3S- 5S Ankrom MA, Shapiro JR: Paget'sdiseaseofbone (osteitis deformans) J Am Geriatr Soc 1998, 46:1025-1033 Thomas DW, Shepherd JP: Paget'sdisease ... al.: Guidelines for diagnosis and management ofPaget'sdiseaseofbone in Japan J Bone Miner Metab 2006, 24:359-367 Kanis JA: Pathophysiology and treatment ofPaget'sdiseaseofbone 1st edition ... techniques of internal fixation This unusual case of delayed union of the femur fracture associated with Paget'sdiseaseof the bone for which functional bracing was ultimately successful illustrates...
... distribution ofPaget'sdiseaseofbone Br Med J 1982, 285:1005-1008 Cooper C, Harvey NC, Dennison EM, van Staa TP: Update on the epidemiology ofPaget'sdiseaseofbone J Bone Miner Res 2006, 21(Suppl ... Biochemical assessment ofPaget'sdiseaseofbone J Bone Miner Res 2006, 21(Suppl 2):22-27 doi: 10.1186/1752-1947-4-166 Cite this article as: Iba et al., Five-year follow-up of Japanese patients with Paget's ... vs etidronate for the treatment ofPaget'sdiseaseofbone J Clin Endocrinal Metab 1996, 81:961-967 12 Woo S- B, Hellstein JW, Kalmar JR: Systematic review: bisphosphonates and osteonecrosis of...
... carcinoma in situ of the breast tissue or lymph node invasion Discussion Pagetsdisease is an eczematous skin change of the nipple that is usually associated with an underlying breast malignancy ... Luini A Pagetsdiseaseof the breast: the experience of the European Institute of Oncology and review of the literature Breast 2008, 112:513-521 Seetharam S, Fentiman IS: Pagetsdiseaseof the ... References Serour F, Birkenfeld S, Amsterdam E, Treshchan O, Krispin M: Pagetsdiseaseof the male breast Cancer 1988, 62:601-605 Harris JR, Hellman S, Henderson CI, Kinne DW: Breast Diseases J B...
... Vulvar Pagetdiseaseof urothelial origin: a report of three cases and a proposed classification of vulvar Pagetdisease Hum Pathol 2002, 33(5):549-554 Lai YL, Yang WG, Tsay PK, Swei H, Chuang SS, ... Photograph of the penile lesion Figure H&E stain of the resected specimen showing a clear margin H&E stain of the resected specimen showing a clear margin Discussion EMPD localised to the penis is extremely ... often non-specific and can mimic any form of dermatosis Differential diagnoses include Bowen 's disease, tinea cruris, contact dermatitis, lichen simplex, lichen planus, psoriasis and seborrheic...
... for Paget'sdisease is to control disease activity with bisphosphonates This is the first reported case ofPaget'sdisease affecting pituitary gland function by involvement of the sphenoid bone ... dysfunction is a common disorder and is an important health-care issue as it acts as a surrogate marker of other diseases of more concern, such as diabetes mellitus and peripheral vascular disease ... Psychogenic Page of (page number not for citation purposes) Journal of Medical Case Reports 2008, 2:234 Paget'sdiseaseofbone (osteitis deformans) is a chronic inflammatory remodelling disease...
... despite the history of ischemic heart disease Niemann and Cairns showed that successfully resuscitated animals not exhibit electrolyte abnormalities [10] and as a result the increased potassium level ... tubular acidosis Intra-cellular potassium release Rhabdomyolysis, tumor lysis syndrome, blood transfusion, hemolysis, beta blockers, digoxin toxicity, low insulin levels Medications Angiotensin-converting ... died of pneumonia 26 days after his cardiac arrest He had paroxysmal atrial fibrillation until his death Discussion Zolendronic acid is a bisphosphonate used in patients with bone metastases from...
... Parkinson sDisease Parkinson sdisease (also known as Parkinson disease or PD) is a degenerative disorder of the central nervous system that often impairs the sufferer s motor skills and speech ... functions, neurotransmitter levels, emotional stress, and progression of neurodegenerative conditions such as Parkinson s and Alzheimer s diseases (Rahman et al., 2008) 11.4 Heart Disease 11.4.1 Case ... minimum of bias and confounding Systematic reviews summarize the existing evidence from groups of RCTs Assessing the methodologic quality of primary studies refers to aspects of study design, performance,...
... robust model of parkinsonism Proceedings of the National Academy of Sciences, of the United States of America, 102, 2174 2179 1: THE ETIOPATHOGENESIS OF PARKINSON S DISEASE: BASIC MECHANISMS OF ... which slows or stops disease progression ACKNOWLEDGEMENT This study was supported by grants from the NIH/NINDS (1 RO1 NS045999-01), the Bendheim Parkinson sDisease Center, and the Morris and ... these positive symptoms of PD ANIMAL MODELS OF PARKINSON SDISEASE AND PARKINSONISM Early animal models of PD were based on lesions of midbrain areas in monkeys (Poirier et al., 1975) These anatomical...
... a-syn, proteins that displayed increased (›) or decreased (fl) expression as a consequence of a-synuclein overexpression; complex, proteins that displayed altered levels as a result of the association ... silver-stained gel images revealed 28 spots whose intensity was significantly different in at least one of the four groups considered (Fig 2) Two groups of spots showing remarkable changes in the isoform ... present study could represent a valuable starting-point for focused investigations aiming to better understand the key issues of PD pathogenesis Materials and methods Cells Human neuroblastoma SH-SY5Y...
... relevance of cross-breeding experiments is strengthened if expression and deletion of the gene (s) results in the opposite outcome, or if the results are substantiated by in vitro studies or analyses of ... models of Alzheimer sdisease dent differences in the speed of Ab accumulation Moreover, transgene expression can differ across generations and give rise to unstable Ab phenotypes because of loss ... Authors Journal compilation ª 2010 FEBS 1391 Animal models of Alzheimer sdisease O Philipson et al Transgenic animal models Models devoid of any disease- causing APP mutations Animal models expressing...
... V All reagents were supplied by Electron Microscopy Sciences (Hatfield, PA, USA) Assessement of SEC-isolated peptides by HPLC and SDS-PAGE Samples (100 lL) of peptides isolated by SEC were injected ... cost-effective than production of synthetic peptides, a bacterial expression system allows isotope labeling, which is essential for high-resolution structural analysis of Ab using NMR spectroscopy ... analysis and sequencing Amino acid analysis was performed at the Amino Acid Analysis Center, University of Uppsala, Sweden Sequence analysis was performed using an Applied Biosystems Procise 492...
... glycosyltransferase; CK, ceramide kinase; CS, ceramide synthase; DES, desaturase; GALC, galactosylceramidase; GBA, glucosylceramidase; GCS, glucosylceramide synthase; SMS, sphingomyelin synthase; ... presentations of the disorder, which often results in severe distal sensory loss and mutilating acropathy [32] Although mutations in SPTLC1 cause neurological disease, there is, as yet, no description ... disease This is based on what we have learned from other neurodegenerative diseases with inclusion pathology For Alzheimer s disease, when pathology was used as a basis to understand the disease, ...
... considered abnormal (12) Statistical Analysis Quantitative variables are described as medians with ranges in parentheses The significance of changes was evaluated us- ing analysis of variance (ANOVA) ... PCDAI was calculated at each visit Stools were cultured at each follow-up visit to assess colonization by LGG Intestinal permeability was assessed by a cellobiosemannitol sugar permeability test at ... immunomodulatory drugs for at least months before screening and stable doses of prednisone for at least weeks before the screening visit Patients were allowed to decrease the steroid dose during the study period...
... neurological, psychiatric and neuropsychological assessments were reviewed in a consensus conference comprised of neurologists, psychiatrists, and neuropsychologists Based on this review all participants ... It has been previously established that APOE variability is not associated with the rate of progression of Alzheimer sdisease [51,59,67] The study was designed to address a specific question ... repetition of phrases from the Boston Diagnostic Aphasia Evaluation [19] Abstract reasoning was evaluated using WAIS-R Similarities subtest [66], and the non-verbal Identities and Oddities subtest of...
... ALZHEIMER SDISEASE AND RELATED DISORDERS This woman is a resident of a home for people with Alzheimer sdisease Because of patients’ memory loss, signs have been posted as reminders of which flowers ... As the disease progresses, however, the entire library of memory closes down Memory loss is probably the most common sign associated with Alzheimer sdisease In the initial stages of the disease, ... is essential in transmission of nerve impulses through the synapses of the brain and central nervous system (A synapse is the point at 33 LIFE OUT OF FOCUS: ALZHEIMER SDISEASE AND RELATED DISORDERS...
... as AD progresses Behavioral and personality changes, including agitation, aggression, and psychosis, often emerge as the disease progresses Depressed mood often occurs with AD Brain autopsies ... Parkinson sdisease than in DLB The diagnosis is supported by a history of syncope, falls, confusion, extreme sensitivity to the movement side effects of neuroleptics, delusions, and other types of ... Cognitive screening includes using validated screening instruments, such as the MMSE, and brief bedside assessments Cognitive screenings are usually sensitive to significant cognitive impairment associated...
... development of a variety of movement disorders These diseases are conventionally categorized into either hypokinetic disorders, such as Parkinson s disease, or hyperkinetic disorders such as hemiballism ... existence of movement disorders such as Huntington sdisease (HD) or dystonia, which seem to cross the boundary between these diseases Another common misconception is that movement disorders are ... this time 3.2 Dyskinetic Disorders In disorders associated with dyskinesias, basal ganglia output is thought to be reduced, resulting in disinhibition of thalamocortical systems and dyskinesias...
... neurodegenerative disease? Insights from an animal model of Parkinsonism Neurobiol Dis 4, 247–253 16 Dauer W & Przedborski S (2003) Parkinson s disease: mechanisms and models Neuron 39, 889–909 ... in the absence of neuronal degeneration [6] The CSF levels of TIQs increase in early PD and decrease as the disease progresses [12] TH inhibition by endogenous TIQs may therefore be most prominent ... cross the mitochondrial membrane [4] High concentrations of N-methyl-salsolinol (NMSal) are required to induce apoptosis of dopaminergic cells in vitro [5], and NMSal causes a loss of tyrosine...